章程修订

Search documents
Graphjet Technology (GTI) 2025 Extraordinary General Meeting Transcript
2025-08-07 14:00
Summary of Graphjet Technology (GTI) Extraordinary General Meeting Company Overview - **Company**: Graphjet Technology (GTI) - **Event**: 2025 Extraordinary General Meeting - **Date**: August 07, 2025 Key Points Industry and Company Context - The meeting was presided over by Chris Lai, the CEO and CFO of Graphjet Technology, indicating a leadership presence and engagement with shareholders [2][3] Voting and Shareholder Participation - A total of 148,037,022 shares were entitled to vote, with 85,436,163 shares (57.713%) present virtually or represented by proxy, demonstrating significant shareholder engagement [5] Share Capital Reorganization - A proposal was made to redesignate and reclassify the company's authorized share capital, which includes: - 479,000,000 Class A ordinary shares at $0.0001 per share - 20,000,000 Class B ordinary shares at $0.001 per share - 1,000,000 preference shares at $0.0001 per share - The proposal aims to consolidate Class A ordinary shares at a ratio between 1:450 and 1:400, effective on or before August 13, 2025 [6][8] Share Consolidation Details - Post-consolidation, shareholders holding between 50 to 150 odd new Class A ordinary shares will hold one new Class A ordinary share with a par value ranging from $0.005 to $0.015 [8] - Any fractional shares resulting from the consolidation will be rounded up to the nearest whole share, ensuring no shareholder is left with fractional entitlements [9] Charter Amendment Proposal - Following the share reorganization, a proposal was made to adopt amended and restated memorandum and articles of association to reflect the changes in share capital and consolidation [10] Voting Results - Preliminary results indicated that at least two-thirds of votes cast by shareholders present and eligible to vote approved: - The share capital reorganization proposal - The share consolidation proposal - The charter amendment proposal [12] Conclusion of Meeting - The meeting concluded with the approval of all proposals, and the inspector of election was directed to submit a final report on the voting outcomes [13] Additional Important Information - The meeting was conducted virtually, reflecting a modern approach to shareholder engagement and participation [2][3] - The presence of legal counsel and board members indicates a structured and compliant approach to corporate governance [3]
易瑞生物: 第三届董事会第十一次会议决议公告
Zheng Quan Zhi Xing· 2025-05-30 11:09
Group 1 - The company held its 11th meeting of the 3rd Board of Directors on May 30, 2025, with all 7 directors present, ensuring compliance with legal and regulatory requirements [1][2] - The Board approved a proposal to expand the business scope to include "inspection and testing services" to meet operational needs [1][2] - As of May 29, 2025, the company's total share capital increased from 400,865,155 shares to 401,317,665 shares due to the conversion of convertible bonds, leading to a corresponding increase in registered capital [1][2] Group 2 - The proposal requires approval from the shareholders' meeting, needing a two-thirds majority of the voting rights present [2] - The company plans to hold its first extraordinary shareholders' meeting of 2025 on June 16, 2025, to discuss the proposal [2]